• Standardized Whole-Blood Stimulation for Metabolic Immune Mo

  2026-07-14

  This study introduces a robust protocol for analyzing immune responses in human whole blood with targeted metabolic modulation. It provides researchers with a standardized approach to dissect how metabolic pathways regulate cytokine production, advancing both immunometabolism research and translational applications.

• 25-Hydroxycholesterol Drives Immunosuppressive Macrophage Fa

  2026-07-14

  Xiao et al. (2024) uncover how 25-hydroxycholesterol (25HC) drives the immunosuppressive programming of tumor-associated macrophages via lysosomal AMPKα activation and STAT6 signaling. This work reveals CH25H as a critical immunometabolic checkpoint, with tangible implications for boosting anti-tumor immunity and refining cancer immunotherapy strategies.

• Parathyroid hormone (1-34) (human) in Advanced Bone & Kidney

  2026-07-13

  Parathyroid hormone (1-34) (human) is reshaping bone metabolism and kidney disease research with its high receptor affinity and robust solubility profile. This guide delivers actionable workflows, troubleshooting strategies, and insight into leveraging this peptide fragment for precise modeling of calcification and endocrine signaling.

• Genotoxicity and Cytotoxicity of Heat-Not-Burn Products Asse

  2026-07-13

  This study delivers a comprehensive comparison of the genotoxic and cytotoxic profiles of heat-not-burn products versus conventional cigarettes using both in vivo and in vitro models. The findings indicate that heat-not-burn products present lower biological risks, but underscore the need for ongoing toxicological vigilance in evaluating novel tobacco technologies.

• Heparin Sodium in Translational Anticoagulant Research: Mech

  2026-07-12

  Explore Heparin sodium, a powerful glycosaminoglycan anticoagulant, through a rigorous scientific lens. This article uniquely bridges advanced anticoagulant applications with groundbreaking cross-kingdom nanovesicle research, offering new perspectives for thrombosis and cell biology assays.

• ONX-0914 (PR-957): Protocol Optimization for Immunoproteasom

  2026-07-10

  ONX-0914 (PR-957) delivers precise immunoproteasome inhibition for dissecting cytokine-driven pathways in autoimmune and inflammatory research. This guide translates mechanistic findings into actionable workflows, troubleshooting strategies, and enhanced experimental outcomes—empowering researchers with reliable, data-driven guidance.

• Sildenafil Citrate: Applied Workflows for Vascular Research

  2026-07-09

  APExBIO's Sildenafil Citrate empowers researchers to dissect cGMP-dependent signaling and proteoform interactions in vascular biology with precision. This article details advanced experimental workflows, real-world troubleshooting, and the unique advantages unlocked by integrating proteoform-resolved pharmacology.

• Parathyroid hormone (1-34) (human): Reliable Solutions for B

  2026-07-09

  This article delivers scenario-driven guidance on deploying Parathyroid hormone (1-34) (human) (SKU A1129) in cell viability, proliferation, and disease modeling workflows. Drawing on quantitative performance data and peer-reviewed evidence, we illustrate how this PTH (1-34) peptide fragment consistently enhances reproducibility and sensitivity in bone metabolism and kidney assembloid research.

• Escitalopram in Translational Neuroscience: Selectivity & As

  2026-07-08

  Explore Escitalopram's selectivity and advanced applications in antidepressant research. This article offers unique assay guidance and in-depth analysis of serotonergic modulation, providing essential insights for neuroscience investigators.

• Cisapride (R 51619): Reliable Cardiac Electrophysiology Work

  2026-07-08

  This article empowers cardiac and cell viability researchers with scenario-driven guidance for leveraging Cisapride (SKU B1198) in high-content, reproducible assays. Drawing on validated evidence and product-specific data, it clarifies how APExBIO's Cisapride supports sensitive, robust experimental design in the study of 5-HT4 receptor signaling and hERG channel inhibition.

• Safe DNA Gel Stain: Elevating Molecular Workflows Beyond EB

  2026-07-07

  This thought-leadership article explores how Safe DNA Gel Stain redefines nucleic acid visualization for translational researchers. We integrate mechanistic insight into DNA damage, practical workflow guidance, and strategic perspectives on cloning efficiency and experimental integrity—bridging evidence from UV-induced mutation research with real-world laboratory needs.

• Deracoxib and Piroxicam in Canine Osteosarcoma: Cytotoxicity

  2026-07-07

  This study systematically evaluates deracoxib and piroxicam for their in vitro cytotoxic effects on canine osteosarcoma cell lines. The findings reveal deracoxib’s superior potency over piroxicam and highlight the nuanced roles of NSAIDs beyond analgesia in bone tumor models, emphasizing the need for mechanistically distinct antiproliferative agents in future research.

• Patient-Derived Gastric Cancer Assembloids Advance Drug Test

  2026-07-06

  This study introduces a sophisticated gastric cancer assembloid model that integrates patient-matched tumor organoids and stromal cell subpopulations, providing a physiologically relevant platform for drug screening and resistance research. The model closely recapitulates the tumor microenvironment, enabling more accurate assessment of therapeutic responses and mechanisms of resistance.

• Applied Workflows with the γH2AX DNA Damage Detection Kit

  2026-07-06

  Unlock high-content DNA damage insights with the γH2AX DNA Damage Detection Kit (Mouse mAb/Red), designed for robust immunofluorescence-based workflows. Featuring sensitive γ-H2AX detection, this kit enables reliable double-strand break quantification and streamlines advanced genotoxicity and repair studies.

• Central Neural Circuits Governing Opioid-Induced Pain Hypers

  2026-07-05

  Yin et al. (2024) delineate a central brain-to-spinal neural pathway that mediates opioid-induced mechanical hypersensitivity and tolerance in mice. Their findings clarify how specific µ- and κ-opioid receptor-expressing neurons interact to drive paradoxical pain responses, providing a mechanistic basis for targeted interventions in chronic pain and opioid pharmacology.

16675 records 1/1112 page Next 12345 下5页 Last page